Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:1899-1905

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, R. C.
Right arrow Articles by Walsh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, R. C.
Right arrow Articles by Walsh, K.
Right arrowPubmed/NCBI databases
*Substance via MeSH

(Circulation. 1997;96:1899-1905.)
© 1997 American Heart Association, Inc.


Articles

Adenoviral Constructs Encoding Phosphorylation-Competent Full-length and Truncated Forms of the Human Retinoblastoma Protein Inhibit Myocyte Proliferation and Neointima Formation

Roy C. Smith, PhD; Ken N. Wills, PhD; Douglas Antelman, PhD; Harris Perlman, BA; Lonn N. Truong, BA; Kevin Krasinski, BA; ; Kenneth Walsh, PhD

From the Division of Cardiovascular Research, Department of Medicine, Tufts University School of Medicine, St. Elizabeth's Medical Center (R.C.S., H.P., L.N.T., K.K., K.W.), Boston, Mass; CANJI, Inc (K.N.W., D.A.), San Diego, Calif; and the Program in Cell, Molecular and Developmental Biology, Sackler School of Biomedical Sciences, Tufts University (H.P., K.W.), Boston, Mass.

Correspondence to Kenneth Walsh, Division of Cardiovascular Research, St Elizabeth's Medical Center, 736 Cambridge St, Boston, MA 02135. E-mail kwalsh{at}opal.tufts.edu

Background The retinoblastoma (Rb) protein is a key cell-cycle regulator that controls entry into the S phase by modulating the activity of the E2F transcription factor. We analyzed the effects of full-length phosphorylation-competent and a mutant truncated form of human Rb for their effects on vascular smooth muscle cell (VSMC) proliferation and neointima formation.

Methods and Results A number of mutant forms, both phosphorylation competent and incompetent, of human Rb protein were evaluated for their ability to inhibit E2F activity. The results of these assays indicated that a phosphorylation competent, amino-terminal–truncated Rb protein (Rb56) was a particularly potent inhibitor of E2F-mediated transcription relative to the full-length Rb construct (Rb110). Adenoviral constructs containing Rb56 or Rb110 expressed their respective Rb forms in VSMCs, as determined by Western immunoblot analysis, and were similar in their abilities to arrest the cell cycle, as determined by assays of 3H-thymidine incorporation and by flow cytometric analyses. When examined for their effect on neointima formation after balloon injury of the rat carotid artery, both full-length and truncated forms of Rb inhibited formation of this VSMC-derived lesion.

Conclusions These analyses revealed that the maintenance of high levels of phosphorylation-competent human Rb, either full-length or truncated forms, in VSMCs is an effective method of modulating the extent of intimal hyperplasia that occurs after balloon-induced vascular injury.


Key Words: angioplasty • genes • carotid arteries • muscle, smooth • stenosis




This article has been cited by other articles:


Home page
EndocrinologyHome page
N. Fiaschi-Taesch, B. Sicari, K. Ubriani, I. Cozar-Castellano, K. K. Takane, and A. F. Stewart
Mutant Parathyroid Hormone-Related Protein, Devoid of the Nuclear Localization Signal, Markedly Inhibits Arterial Smooth Muscle Cell Cycle and Neointima Formation by Coordinate Up-Regulation of p15Ink4b and p27kip1
Endocrinology, March 1, 2009; 150(3): 1429 - 1439.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. S. M. Boesten, A. S. M. Zadelaar, A. van Nieuwkoop, L. Hu, J. Jonkers, B. van de Water, M. J. J. Gijbels, I. van der Made, M. P. J. de Winther, L. M. Havekes, et al.
Macrophage retinoblastoma deficiency leads to enhanced atherosclerosis development in ApoE-deficient mice
FASEB J, May 1, 2006; 20(7): 953 - 955.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
A. Chandiwal, V. Balasubramanian, Z. K. Baldwin, M. S. Conte, and L. B. Schwartz
Gene Therapy for the Extension of Vein Graft Patency: A Review
Vascular and Endovascular Surgery, January 1, 2005; 39(1): 1 - 14.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. E. Zettler, M. A. Prociuk, J. A. Austria, H. Massaeli, G. Zhong, and G. N. Pierce
OxLDL stimulates cell proliferation through a general induction of cell cycle proteins
Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H644 - H653.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Perlman, K. Bradley, H. Liu, S. Cole, E. Shamiyeh, R. C. Smith, K. Walsh, S. Fiore, A. E. Koch, G. S. Firestein, et al.
IL-6 and Matrix Metalloproteinase-1 Are Regulated by the Cyclin-Dependent Kinase Inhibitor p21 in Synovial Fibroblasts
J. Immunol., January 15, 2003; 170(2): 838 - 845.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Kotani, N. Fukuda, H. Ando, W.-Y. Hu, S. Kunimoto, S. Saito, and K. Kanmatsuse
Chimeric DNA-RNA hammerhead ribozyme targeting PDGF A-chain mRNA specifically inhibits neointima formation in rat carotid artery after balloon injury
Cardiovasc Res, January 1, 2003; 57(1): 265 - 276.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. CONDORELLI, J. K. AYCOCK, G. FRATI, and C. NAPOLI
Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice
FASEB J, October 1, 2001; 15(12): 2162 - 2170.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Minter, M. A. Ferry, M. E. Murday, C. L. Tannahill, F. R. Bahjat, C. Oberholzer, A. Oberholzer, D. LaFace, B. Hutchins, S. Wen, et al.
Adenoviral Delivery of Human and Viral IL-10 in Murine Sepsis
J. Immunol., July 15, 2001; 167(2): 1053 - 1059.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. J. Cua, B. Hutchins, D. M. LaFace, S. A. Stohlman, and R. L. Coffman
Central Nervous System Expression of IL-10 Inhibits Autoimmune Encephalomyelitis
J. Immunol., January 1, 2001; 166(1): 602 - 608.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. M. Minter, M. A. Ferry, J. E. Rectenwald, F. R. Bahjat, A. Oberholzer, C. Oberholzer, D. La Face, V. Tsai, C. M. I. Ahmed, B. Hutchins, et al.
Extended lung expression and increased tissue localization of viral IL-10 with adenoviral gene therapy
PNAS, December 22, 2000; (2000) 250489297.
[Abstract] [Full Text]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
S. L. Meyerson, C. L. Skelly, M. A. Curi, and L. B. Schwartz
Gene Therapy for Cardiovascular Disease
Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2000; 4(4): 289 - 300.
[Abstract] [PDF]


Home page
Circ. Res.Home page
M. R. Kibbe, T. R. Billiar, and E. Tzeng
Gene Therapy for Restenosis
Circ. Res., April 28, 2000; 86(8): 829 - 833.
[Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Minter, J. E. Rectenwald, K. Fukuzuka, C. L. Tannahill, D. La Face, V. Tsai, I. Ahmed, E. Hutchins, R. Moyer, E. M. Copeland III, et al.
TNF-{alpha} Receptor Signaling and IL-10 Gene Therapy Regulate the Innate and Humoral Immune Responses to Recombinant Adenovirus in the Lung
J. Immunol., January 1, 2000; 164(1): 443 - 451.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. P. Claudio, L. Fratta, F. Farina, C. M. Howard, G. Stassi, S.-i. Numata, C. Pacilio, A. Davis, M. Lavitrano, M. Volpe, et al.
Adenoviral RB2/p130 Gene Transfer Inhibits Smooth Muscle Cell Proliferation and Prevents Restenosis After Angioplasty
Circ. Res., November 26, 1999; 85(11): 1032 - 1039.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Mano, Z. Luo, S. L. Malendowicz, T. Evans, and K. Walsh
Reversal of GATA-6 Downregulation Promotes Smooth Muscle Differentiation and Inhibits Intimal Hyperplasia in Balloon-Injured Rat Carotid Artery
Circ. Res., April 2, 1999; 84(6): 647 - 654.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Fareh, R. Martel, P. Kermani, and G. Leclerc
Cellular Effects of ß-Particle Delivery on Vascular Smooth Muscle Cells and Endothelial Cells : A Dose-Response Study
Circulation, March 23, 1999; 99(11): 1477 - 1484.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Wu, P. Chen, J.-J. Hwang, L. W. Barsky, K. I. Weinberg, A. Jong, and V. A. Starnes
RNA Antisense Abrogation of MAT1 Induces G1 Phase Arrest and Triggers Apoptosis in Aortic Smooth Muscle Cells
J. Biol. Chem., February 26, 1999; 274(9): 5564 - 5572.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Sata, H. Perlman, D. A. Muruve, M. Silver, M. Ikebe, T. A. Libermann, P. Oettgen, and K. Walsh
Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response
PNAS, February 3, 1998; 95(3): 1213 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. M. Minter, M. A. Ferry, J. E. Rectenwald, F. R. Bahjat, A. Oberholzer, C. Oberholzer, D. La Face, V. Tsai, C. M. I. Ahmed, B. Hutchins, et al.
Extended lung expression and increased tissue localization of viral IL-10 with adenoviral gene therapy
PNAS, January 2, 2001; 98(1): 277 - 282.
[Abstract] [Full Text] [PDF]